2009•Zhonghua shiyan waike zazhiRequires access

Induction of tolerance to mouse skin allograft by donor bone marrow-derived immature dendritic cells combined with rapamycin

余思, 付必莽, 何晓顺, 胡安斌, 马毅, 黄洁夫

Open publisher page 0 citations

Abstract

Objective To investigate the synergic effects of donor bone marrow-derived immature dendritic cells combined with rapamycin on induction of tolerance to skin allograft in mice. Methods An allogenic skin transplantation model was established with the donors C57BL/6 mice and the recipients BALB/C mice. Recipients were divided into 4 groups : control group ( no administration before or after skin transplantation) , rapamycin group (receiving rapamycin 1 mg/kg^-1·d^-1 by garage for consecutive 7 days after skin transplantation) ,immature DC group (receiving an injection of donor bone marrow-derived immature DC via tail vein before skin transplantation), combined group (receiving an injection of donor bone marrow-derived immature DC via tail vein before transplantation and rapamycin 1 mg/kg^-1·d^-1 by garage for consecutive 7 days after transplantation). The survival time of skin allograft was observed. Results The survival time of skin allograft in the groups of control, rapamycin, immature DC, and immature DC ± rapamyein was (6.9 ± 1.9 ), ( 10.3 ± 3.0), ( 17.0 ± 3.4 ), and ( 20.8 ± 3.6 ) days respectively. Statistical analysis showed that there was significant difference among groups ( P 〈 0.05 ) ; Furthermore, S-N-K test showed that there was significant difference between every two groups. Conclusion There were synergic effects for donor bone marrow-derived immature dendritic cells and rapamycin in induction of tolerance to skin allograft in mice. Key words: Dendritic cells;  Rapamyein;  Immune tolerance;  Skin transplantation

About this research paper

What this paper is about

Objective To investigate the synergic effects of donor bone marrow-derived immature dendritic cells combined with rapamycin on induction of tolerance to skin allograft in mice. Methods An allogenic skin transplantation model was established with the donors C57BL/6 mice and the recipients BALB/C mice. Recipients were divided into 4 groups : control group ( no administration before or after skin transplantation) , rapamycin group (receiving rapamycin 1 mg/kg^-1·d^-1 by garage for consecutive 7 days after skin transplantation) ,immature DC group (receiving an injection of donor bone marrow-derived immature DC via tail vein before skin transplantation), combined group (receiving an injection of donor bone marrow-derived immature DC via tail vein before transplantation and rapamycin 1 mg/kg^-1·d^-1 by garage for consecutive 7 days after transplantation). The survival time of skin allograft was observed. Results The survival time of skin allograft in the groups of control, rapamycin, immature DC, and immature DC ± rapamyein was (6.9 ± 1.9 ), ( 10.3 ± 3.0), ( 17.0 ± 3.4 ), and ( 20.8 ± 3.6 ) days respectively. Statistical analysis showed that there was significant difference among groups ( P 〈 0.05 ) ; Furthermore, S-N-K test showed that there was significant difference between every two groups. Conclusion There were synergic effects for donor bone marrow-derived immature dendritic cells and rapamycin in induction of tolerance to skin allograft in mice. Key words: Dendritic cells;  Rapamyein;  Immune tolerance;  Skin transplantation

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the synergic effects of donor bone marrow-derived immature dendritic cells combined with rapamycin on induction of tolerance to skin allograft in mice. Methods An allogenic skin transplantation model was established with the donors C57BL/6 mice and the recipients BALB/C mice. Recipients were divided into 4 groups : control group ( no administration before or after skin transplantation) , rapamycin group (receiving rapamycin 1 mg/kg^-1·d^-1 by garage for consecutive 7 days after skin transplantation) ,immature DC group (receiving an injection of donor bone marrow-derived immature DC via tail vein before skin transplantation), combined group (receiving an injection of donor bone marrow-derived immature DC via tail vein before transplantation and rapamycin 1 mg/kg^-1·d^-1 by garage for consecutive 7 days after transplantation). The survival time of skin allograft was observed. Results The survival time of skin allograft in the groups of control, rapamycin, immature DC, and immature DC ± rapamyein was (6.9 ± 1.9 ), ( 10.3 ± 3.0), ( 17.0 ± 3.4 ), and ( 20.8 ± 3.6 ) days respectively. Statistical analysis showed that there was significant difference among groups ( P 〈 0.05 ) ; Furthermore, S-N-K test showed that there was significant difference between every two groups. Conclusion There were synergic effects for donor bone marrow-derived immature dendritic cells and rapamycin in induction of tolerance to skin allograft in mice. Key words: Dendritic cells;  Rapamyein;  Immune tolerance;  Skin transplantation

Key concepts: Transplantation, Bone marrow, Medicine, Immune tolerance, Immune system, Dendritic cell, Andrology, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
Induction of tolerance to mouse skin allograft by donor bone marrow-derived immature dendritic cells combined with rapamycin — Research Paper | ScholarLens